ZYBT
Zhengye Biotechnology Holding Limited
1.30$
+5.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 37.0% | 41.2% | 41.1% | 36.0% | 31.5% | |
| 1.4% | 1.9% | 3.0% | 3.8% | 11.5% | |
| 1.4% | 1.9% | 3.3% | – | 11.9% | |
| 22.9% | 25.8% | 19.9% | 12.1% | 4.2% | |
| 9.8% | 10.7% | 11.7% | 11.8% | 9.0% | |
| 2.7% | 3.7% | 3.3% | 4.6% | 12.5% | |
| 28.4% | 31.3% | 32.1% | 28.5% | 29.7% | |
| 28.2% | 29.3% | 30.1% | 27.6% | 27.6% | |
| 6.7% | 10.6% | 16.0% | – | 15.1% | |
| 17.4% | 15.3% | 9.1% | 8.7% | 10.1% | |
| – | 1.9% | 2.0% | 1.0% | 2.0% | |
| 60.1% | 57.1% | 54.6% | 57.6% | 57.2% | |
| 9.5% | 12.7% | 7.7% | 9.8% | -5.0% | |
| 10.6% | 9.1% | 9.4% | 9.6% | 10.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.